FDA approves Amgen’s combo therapy for colorectal cancer
Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA ...
Leading Sales and Marketing Intent Data, Database and D...
Discover leading Sales & Marketing Intent Data Solutions for the Pharmaceutical ...
COPD market to expand with AstraZeneca’s focus on biolo...
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to so...